Back

Watch Compare

BIODESIX INC

Data quality: 100%

BDSX

Nasdaq Services Health Services

$12.90

▼ $1.35 (-9.47%)

Mkt Cap: 127.17 M

Price

$12.90

Mkt Cap

127.17 M

Day Range

$12.88 — $14.37

52-Week Range

$3.44 — $20.21

Volume

36,703

Open $14.07

50D / 200D Avg

$13.84

6.76% below

50D / 200D Avg

$9.04

42.69% above

Quick Summary

Key Takeaways

Revenue grew 12.88% annually over 5 years — strong growth

Negative free cash flow of -23.53 M

Revenue growth is accelerating — 1Y growth exceeds 5Y average by 11.20%

Capital efficient — spends only 0.29% of revenue on capex

Growth

Revenue Growth (5Y)

12.88%

Above sector avg (4.21%)

Revenue (1Y)24.08%

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Quality

Return on Equity

N/A

ROIC-30.76%

Net Margin-39.85%

Op. Margin-31.50%

Safety

Debt / Equity

N/A

Current Ratio1.84

Interest Coverage-3.61

Valuation

PE (TTM)

-3.61

Below sector avg (-1.17)

P/B RatioN/A

EV/EBITDAN/A

Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (502 peers)

Metric	Stock	Sector Median
P/E	-3.6	-1.2
P/B	—	1.4
ROE %	—	-15.7
Net Margin %	-39.9	-18.3
Rev Growth 5Y %	12.9	4.2
D/E	—	0.4

ETFs Holding This Stock

BRSIX BRSIX

0.07% weight

All Fundamental Metrics

Growth
Revenue Growth (1Y)	24.08%	Revenue Growth (3Y)	34.27%
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	12.88%	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	88.50 M	Net Income (TTM)	-35.27 M
ROE	N/A	ROA	-39.97%
Gross Margin	N/A	Operating Margin	-31.50%
Net Margin	-39.85%	Free Cash Flow (TTM)	-23.53 M
ROIC	-30.76%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	N/A	Current Ratio	1.84
Interest Coverage	-3.61	Asset Turnover	1.00
Working Capital	15.25 M	Tangible Book Value	-21.13 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-3.61	Forward P/E	N/A
P/B Ratio	N/A	P/S Ratio	1.44
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-18.50%
Market Cap	127.17 M	Enterprise Value	160.58 M
Per Share
EPS (Diluted TTM)	-4.67	Revenue / Share	8.98
FCF / Share	-2.39	OCF / Share	-2.36
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	0.29%	FCF Conversion	66.72%
SBC-Adj. FCF	-28.11 M	Growth Momentum	11.20

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	88.50 M	71.32 M	49.09 M	38.21 M	54.51 M
Net Income	-35.27 M	-42.93 M	-52.15 M	-65.45 M	-43.16 M
EPS (Diluted)	-4.67	-0.33	-0.64	-1.55	—
Gross Profit	—	—	—	—	—
Operating Income	-27.87 M	-34.50 M	-41.34 M	-50.59 M	-40.94 M
EBITDA	—	—	—	—	—
R&D Expenses	12.00 M	9.56 M	9.99 M	13.10 M	12.79 M
SG&A Expenses	87.55 M	80.45 M	67.39 M	61.46 M	50.52 M
D&A	5.67 M	5.77 M	3.33 M	3.60 M	3.18 M
Interest Expense	7.72 M	8.26 M	9.54 M	8.07 M	4.51 M
Income Tax	0.0	0.0	0.0	0.0	0.0

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	87.48 M	97.24 M	99.10 M	92.91 M	76.10 M
Total Liabilities	89.94 M	76.37 M	94.52 M	72.30 M	56.37 M
Shareholders' Equity	-2.47 M	20.88 M	4.58 M	20.61 M	19.73 M
Total Debt	50.01 M	40.03 M	40.08 M	30.13 M	10.08 M
Cash & Equivalents	18.99 M	26.25 M	26.28 M	43.09 M	32.71 M
Current Assets	32.52 M	39.48 M	39.68 M	53.33 M	43.61 M
Current Liabilities	17.44 M	14.32 M	33.42 M	22.84 M	28.96 M